Opening the evidence
Loading published checks.Find the moment. Check the finding.
Search claims, explanations, guests and episode titles. Speaker names appear when attribution has been confirmed.
The Sinclair lab study on NMN restoring blood vessel growth in older mice was published in Cell in 2018, not 2012, and the mechanism involved restoring an NAD+ dependent signaling pathway rather than simply eliminating one protein. Treated mice regained capillary density and saw a 56 to 80 percent boost in endurance.
A real study out of Central South University in China did use OSK gene therapy in mice with damaged joints, so the basic story checks out. But the study's actual findings were about protecting cartilage and normalizing bone density changes around the joint, not fully regrowing muscle and bone back to normal the way the claim describes.
There's genuine research into reversing brain aging through epigenetic reprogramming, and Sinclair has said he believes this could one day help Alzheimer's patients. But right now there's no cure or reversal for Alzheimer's disease, only treatments that can slow its progression, so stating it 'can be reversed' overstates where the science actually stands today.
This is out of date. The UFC and USADA ended their partnership, with USADA testing stopping as of January 1, 2024. The UFC now runs its anti-doping program through Drug Free Sport International instead, so fighters haven't been under USADA's random testing for a while now.
The reporting is real and it is worse in some ways than the claim. Hannah Dreier's New York Times series found sponsor vetting rushed under pressure to move children through quickly, follow-up checks done by phone, and HHS unable to reach more than 85,000 children after placement. What it documented was a system buckling, not an agency formally taking its vetting apart. The series won a Pulitzer and led to policy changes.
There is a real number close to this, but it belongs to a different agency and means something narrower. A DHS Inspector General report in August 2024 found ICE had not served court dates to more than 291,000 unaccompanied minors, with another 32,000 who missed the dates they were given. That is roughly 320,000, and it describes a court notification failure at DHS rather than HHS losing track of where children physically are.
Publicly funded, privately delivered. Canada's Medicare pays the bills through provincial insurance plans, but the doctors and most hospitals are not government owned and physicians largely run their own practices. Socialised medicine usually means the state employs the providers, which is closer to Britain's NHS than to Canada's system.
While chronic disease rates in children have genuinely increased, Kennedy's specific figures (12% in 1986 → 54% today) are disputed. The 54% figure appears to derive from a 2011 JAMA Pediatrics study measuring any chronic condition broadly, including mild conditions like skin allergies. More targeted analyses show lower rates. The trend of increasing chronic disease is real, but the specific percentage is likely inflated by expansive definitions of 'chronic condition.' Causally linking this solely to vaccines is not supported by evidence.
The frog half has real research behind it. Tyrone Hayes at Berkeley found atrazine chemically castrated three quarters of exposed male frogs and turned some into functional females, at concentrations well under the EPA's 3 parts per billion drinking water limit. The human hormone half is where it outruns the evidence. That link is still uncertain, and the EPA has kept atrazine registered while Europe banned it in 2003.
This is a genuine split between agencies, not a settled fact either way. The World Health Organization's cancer agency classifies glyphosate as probably carcinogenic to humans. The EPA concluded it is not likely to be, though a federal appeals court in 2022 found the agency had ignored studies and sidelined its own advisory panel in reaching that. Stating it flatly as causing cancer skips over a real disagreement.
The National Childhood Vaccine Injury Act (1986) shifted vaccine injury claims from courts to the Vaccine Injury Compensation Program (VICP), a no-fault system funded by an excise tax. Manufacturers are not completely immune — they can still be sued for manufacturing defects, failure to warn, or intentional wrongful conduct. Since 2010, the Emergency Use Authorization framework provided additional liability protection. Kennedy consistently conflates VICP with 'total immunity', which is legally inaccurate.
Studies by Christopher Shaw (later retracted for data irregularities) alleged aluminum in vaccine adjuvants causes neurological damage. The mainstream scientific consensus is that aluminum adjuvants are safe at vaccine doses — the body excretes the vast majority within days. Infants receive far more aluminum through breast milk and infant formula than from vaccines. Research from the European Journal of Vaccines & Immunization and WHO SAGE Working Group on vaccine safety both concluded the evidence for adjuvant-related neurotoxicity is not established.
Some were, some were not, and the reason matters. Saline placebos have been used in vaccine trials going back to Salk's 1954 polio trial, and rotavirus vaccines on the current schedule were tested that way too. For others, running an inert placebo would mean leaving children unprotected against a disease we already have a vaccine for, so trials compare the new vaccine against the existing one instead. That is an ethics call, not a gap nobody noticed.
Intentionally is the part that does not hold. V-safe was built to catch common short-term reactions through daily check-ins, and it did flag when someone needed medical care or missed work. It was never the channel for unusual or serious events, which is what VAERS is for, and it was not designed to establish cause. Being narrow by design is different from being built to suppress.
He said something close to this, and the wording matters. Thompson issued a statement through his lawyer in August 2014 saying he and his co-authors left out a finding about African American boys vaccinated before 36 months. The destroying part comes from a taped call with Brian Hooker, read into the congressional record, describing co-authors putting hard copies in a bin. The underlying dataset was kept, and Thompson has never said the results were falsified.
Myocarditis was identified as an extremely rare adverse event early in the rollout, but clinical trials for tens of thousands of participants were not large enough to detect such rare events before the EAU/Full Approval stages.
While many recovered, thousands were hospitalized and 400-500 died annually in the US alone before the vaccine. Calling it 'mild' ignores the significant morbidity and mortality rates associated with the disease.
The general point about vaccine trials is stronger than this specific framing. Vaccine trials often compare against an existing vaccine rather than saline, because withholding protection from infants in a trial raises an ethics problem. That is a real design tradeoff worth arguing about, but the choice is made openly and for a stated reason, not hidden.
MMR clinical trials often used active controls because withholding the vaccine from a control group would expose children to dangerous, highly contagious diseases. This is a standard ethical practice in clinical research.
While the 1986 Act provides significant liability protection for design defects and side effects, it is not 'complete' immunity. Lawsuits can still be filed for manufacturing defects, negligence, or if the company failed to warn of known risks.
Flagged claims only. “Unverified” means unresolved, not false. Topic labels help browsing and are not evidence.